摘要
Adult-onset brain cancers,such as glioblastomas,are particularly lethal.People with glioblastoma multiforme(GBM)do not anticipate living for more than 15 months if there is no cure.The results of conventional treatments over the past 20 years have been underwhelming.Tumor aggressiveness,location,and lack of systemic therapies that can penetrate the blood–brain barrier are all contributing factors.For GBM treatments that appear promising in preclinical studies,there is a considerable rate of failure in phaseⅠandⅡclinical trials.Unfortunately,access becomes impossible due to the intricate architecture of tumors.In vitro,bioengineered cancer models are currently being used by researchers to study disease development,test novel therapies,and advance specialized medications.Many different techniques for creating in vitro systems have arisen over the past few decades due to developments in cellular and tissue engineering.Later-stage research may yield better results if in vitro models that resemble brain tissue and the blood–brain barrier are used.With the use of 3D preclinical models made available by biomaterials,researchers have discovered that it is possible to overcome these limitations.Innovative in vitro models for the treatment of GBM are possible using biomaterials and novel drug carriers.This review discusses the benefits and drawbacks of 3D in vitro glioblastoma modeling systems.
